BrainStorm Cell Therapeutics (BCLI) Fails to deliver data

Key failure to deliver metrics for BrainStorm Cell Therapeutics:

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: NZ$0 M
• Last 12 months FTD volume: NZ$6.32 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BrainStorm Cell Therapeutics (BCLI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BrainStorm Cell Therapeutics (BCLI) - since 2024

BrainStorm Cell Therapeutics (BCLI) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	NZ$60.15 M	NZ$0.26 B	🇺🇸 USA
Cytokinetics CYTK	NZ$18.27 M	NZ$35.97 M	🇺🇸 USA
Seagen SGEN	N/A	NZ$3.02 M	🇺🇸 USA
Biogen BIIB	NZ$22.86 M	NZ$94.5 M	🇺🇸 USA
Agenus AGEN	NZ$0.39 M	NZ$3.49 M	🇺🇸 USA